FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Refining Cardiovascular-Kidney-Metabolic Risk Assessment Across the Heart Failure Spectrum

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: The cardiovascular-kidney-metabolic (CKM) framework emphasizes risk assessment and prevention of heart failure (HF). However, the prognostic implications and optimal assessment of CKM burden in established HF remain uncertain. Objectives: To evaluate the prognostic value of binary and HF-adapted graded CKM burden scores across HF phenotypes. Methods: We evaluated 2 independent HF cohorts comprising patients with HF with reduced ejection fraction (HFrEF) initiating angiotensin receptor-neprilysin inhibitor therapy (HFrEF-ARNI; n=1,450) and patients hospitalized for acute HF (AHF; n
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.